https://www.pharmaglobenewswire.com/parkinsons-disease-levodopa-induced-dyskinesia-market-set-to-witness-significant-growth-driven-by-rising-prevalence-pipeline-advancements-and-expanding-therapeutic-options-through-2034/Pharma Globenewswireen2026-07-21T10:06:35+01:00Parkinson’s Disease Levodopa-Induced Dyskinesia Market Set to Witness Significant Growth Driven by Rising Prevalence, Pipeline Advancements, and Expanding Therapeutic Options Through 2034 https://www.pharmaglobenewswire.com/inclusion-body-myositis-therapeutics-market-size-in-the-7mm-is-anticipated-to-increase-at-a-significant-cagr-by-2034-estimates-delveinsight-2/Pharma Globenewswireen2026-07-21T07:39:04+01:00Inclusion Body Myositis Therapeutics Market Size in the 7MM is anticipated to increase at a significant CAGR by 2034, estimates DelveInsight https://www.pharmaglobenewswire.com/spinocerebellar-ataxias-pipeline-gains-momentum-with-10-emerging-therapies-across-clinical-development-driven-by-advances-in-gene-silencing-and-regenerative-medicine/Pharma Globenewswireen2026-07-21T05:55:37+01:00Spinocerebellar Ataxias Pipeline Gains Momentum with 10+ Emerging Therapies Across Clinical Development, Driven by Advances in Gene-Silencing and Regenerative Medicine https://www.pharmaglobenewswire.com/ovarian-cancer-market-set-to-witness-significant-growth-driven-by-rising-disease-burden-pipeline-advancements-and-expanding-targeted-therapies-through-2034/Pharma Globenewswireen2026-07-20T11:33:54+01:00Ovarian Cancer Market Set to Witness Significant Growth Driven by Rising Disease Burden, Pipeline Advancements, and Expanding Targeted Therapies Through 2034 https://www.pharmaglobenewswire.com/healthcare-analytics-market-market-insights-trends-and-forecast-2034/Pharma Globenewswireen2026-07-20T07:41:17+01:00Healthcare Analytics Market Market Insights, Trends and Forecast 2034 https://www.pharmaglobenewswire.com/alk-positive-non-small-cell-lung-cancer-pipeline-landscape-reveals-promising-therapeutic-advances/Pharma Globenewswireen2026-07-20T07:32:53+01:00ALK-Positive Non-Small Cell Lung Cancer Pipeline Landscape Reveals Promising Therapeutic Advances